ENST00000439032.6:n.430G>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000439032.6(EGR2):​n.430G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0578 in 152,320 control chromosomes in the GnomAD database, including 362 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.058 ( 362 hom., cov: 34)

Consequence

EGR2
ENST00000439032.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.764

Publications

3 publications found
Variant links:
Genes affected
EGR2 (HGNC:3239): (early growth response 2) The protein encoded by this gene is a transcription factor with three tandem C2H2-type zinc fingers. Defects in this gene are associated with Charcot-Marie-Tooth disease type 1D (CMT1D), Charcot-Marie-Tooth disease type 4E (CMT4E), and with Dejerine-Sottas syndrome (DSS). Multiple transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
EGR2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4E
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • Charcot-Marie-Tooth disease
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 1D
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 3
    Inheritance: SD, AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-62815600-C-G is Benign according to our data. Variant chr10-62815600-C-G is described in ClinVar as Benign. ClinVar VariationId is 669763.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.19 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EGR2NM_000399.5 linkc.169+261G>C intron_variant Intron 1 of 1 ENST00000242480.4 NP_000390.2 P11161-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EGR2ENST00000242480.4 linkc.169+261G>C intron_variant Intron 1 of 1 1 NM_000399.5 ENSP00000242480.3 P11161-1

Frequencies

GnomAD3 genomes
AF:
0.0577
AC:
8787
AN:
152202
Hom.:
360
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0153
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.0562
Gnomad ASJ
AF:
0.0467
Gnomad EAS
AF:
0.200
Gnomad SAS
AF:
0.0850
Gnomad FIN
AF:
0.0625
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0702
Gnomad OTH
AF:
0.0564
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0578
AC:
8797
AN:
152320
Hom.:
362
Cov.:
34
AF XY:
0.0578
AC XY:
4303
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0153
AC:
636
AN:
41588
American (AMR)
AF:
0.0560
AC:
858
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0467
AC:
162
AN:
3470
East Asian (EAS)
AF:
0.200
AC:
1032
AN:
5160
South Asian (SAS)
AF:
0.0853
AC:
412
AN:
4830
European-Finnish (FIN)
AF:
0.0625
AC:
663
AN:
10616
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0701
AC:
4770
AN:
68026
Other (OTH)
AF:
0.0619
AC:
131
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
452
905
1357
1810
2262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0593
Hom.:
34
Bravo
AF:
0.0549
Asia WGS
AF:
0.142
AC:
492
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
16
DANN
Benign
0.83
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2297489; hg19: chr10-64575360; API